Literature DB >> 17297282

The peculiarities of Pseudomonas aeruginosa resistance to antibiotics and prevalence of serogroups.

Greta Gailiene1, Alvydas Pavilonis, Violeta Kareiviene.   

Abstract

UNLABELLED: Pseudomonas aeruginosa is one of the most common nonfermenting aerobic gram-negative microorganisms identified in clinical specimens of hospitalized patients. The emergence of multidrug-resistant (MDR) Pseudomonas aeruginosa strains is a growing concern in hospital-acquired infections. Typing of strains is important for identifying the sources of infection as well as prevention of cross-infections and monitoring of the efficacy of antimicrobial therapy. The aim of this study was to evaluate the antimicrobial resistance and prevalence of Pseudomonas aeruginosa serogroups isolated at Kaunas University of Medicine Hospital, Lithuania.
MATERIAL AND METHODS: Minimum inhibitory concentrations of piperacillin, cefoperazone, ceftazidime, cefotaxime, cefepime, imipenem, meropenem, gentamicin, amikacin, tobramycin, and ciprofloxacin for 609 Pseudomonas aeruginosa strains isolated from various clinical specimens between November 2001 and November 2002 were determined by the microdilution method in Mueller-Hinton agar using interpretative guidelines of National Committee for Clinical Laboratory Standards. Serogroups of Pseudomonas aeruginosa strains were identified using serums of Seiken Co. Ltd (Tokyo, Japan), containing antibodies against antigens of Pseudomonas aeruginosa O-group.
RESULTS: Pseudomonas aeruginosa strains were the most sensitive to ceftazidime (78.9%), imipenem (73.6%), meropenem (70.9%) and the most resistant to gentamicin (54.1%) and ciprofloxacin (52.5%). Multidrug-resistant strains made up 9.85% of all Pseudomonas aeruginosa strains investigated. Multidrug-resistant Pseudomonas aeruginosa strains were 1.5-3.5 times more resistant to antibiotics compared to non-multidrug-resistant strains, except to amikacin: multidrug-resistant strains were more sensitive (81.7%) than non-multidrug-resistant Pseudomonas aeruginosa strains (61.0%). Pseudomonas aeruginosa serogroups O:E and O:B were the most common serogroups (34.7% and 29.0%, respectively) followed by serogroups O:I (11.4%) and O:A (10.1%). Pseudomonas aeruginosa serogroup O:E strains were the most prevalent among multidrug-resistant strains (48.3%).
CONCLUSIONS: The results of our study show that serogroup O:E was the most prevalent serogroup of Pseudomonas aeruginosa in our hospital, and its resistance to antibiotics was the highest.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17297282

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  4 in total

1.  Metallo-beta-Lactamase VIM-1, SPM-1, and IMP-1 Genes Among Clinical Pseudomonas aeruginosa Species Isolated in Zahedan, Iran.

Authors:  Mehdi Ghamgosha; Shahram Shahrekizahedani; Farshid Kafilzadeh; Zakaria Bameri; Ramezan Ali Taheri; Gholamreza Farnoosh
Journal:  Jundishapur J Microbiol       Date:  2015-04-18       Impact factor: 0.747

2.  Antibacterial activity of amino- and amido- terminated poly (amidoamine)-G6 dendrimer on isolated bacteria from clinical specimens and standard strains.

Authors:  Ayoob Rastegar; Shahram Nazari; Ahmad Allahabadi; Farahnaz Falanji; Fakhreddin Akbari Dourbash Akbari Dourbash; Zahra Rezai; Soudabeh Alizadeh Matboo; Reza Hekmat-Shoar; Seyed Mohsen Mohseni; Gharib Majidi
Journal:  Med J Islam Repub Iran       Date:  2017-09-24

3.  Enumerating Antibiotic Susceptibility Patterns of Pseudomonas aeruginosa Isolated from Different Sources in Dhaka City.

Authors:  Mahmudullah Bhuiya; Mohammad K I Sarkar; Mehadi H Sohag; Hafij Ali; Chapol K Roy; Lutfa Akther; Abu F Sarker
Journal:  Open Microbiol J       Date:  2018-05-31

4.  Antibacterial activities of Dodonaea viscosa using contact bioautography technique.

Authors:  Muhammad Khurram; Murad Ali Khan; Abdul Hameed; Naz Abbas; Abdul Qayum; Humaira Inayat
Journal:  Molecules       Date:  2009-03-26       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.